Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (91-100 of 315) with videos related to

Pageof 32
Sort By:
BMC Biology|January 8, 2026
Increased prolactin levels in pregnancy affect colorectal cancer aggressivenessMaria Lopez-Cavestany, Olivia A Wright, Alexandria T Carter, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 7, 2007
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumabRavi Murthy, Cathy Eng, Sunil Krishnan, et al.
Oncotarget|April 29, 2020
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancerCathy Eng, Marwan Fakih, Manik Amin, et al.
The Oncologist|March 7, 2015
Challenges of efficacy assessments in pseudomyxoma peritoneaMichael J Overman, Cathy Eng, Kanwal Raghav, et al.
Investigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.
BMJ Open|January 18, 2022
Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysisNina Arhin, Paddy Ssentongo, Morris Taylor, et al.
Diseases of the Colon and Rectum|July 21, 2009
A twenty-year experience with adenocarcinoma of the anal canalGeorge J Chang, Ricardo J Gonzalez, John M Skibber, et al.
Expert Opinion on Biological Therapy|August 1, 2022
Biologics in rectal cancerAlexandre A Jácome, Renata D'Alpino Peixoto, Mariana V Gil, et al.
The Oncologist|May 27, 2025
Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancerChristopher Cann, Michael LaPelusa, Sarah Cimino, et al.
Journal of Pain and Symptom Management|February 9, 2018
The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled TrialSarah Prinsloo, Diane Novy, Larry Driver, et al.
Pageof 32

Showing results (91-100 of 315) with videos related to

Sort By:
Pageof 32
BMC Biology|January 8, 2026
Increased prolactin levels in pregnancy affect colorectal cancer aggressivenessMaria Lopez-Cavestany, Olivia A Wright, Alexandria T Carter, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 7, 2007
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumabRavi Murthy, Cathy Eng, Sunil Krishnan, et al.
Oncotarget|April 29, 2020
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancerCathy Eng, Marwan Fakih, Manik Amin, et al.
The Oncologist|March 7, 2015
Challenges of efficacy assessments in pseudomyxoma peritoneaMichael J Overman, Cathy Eng, Kanwal Raghav, et al.
Investigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.
BMJ Open|January 18, 2022
Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysisNina Arhin, Paddy Ssentongo, Morris Taylor, et al.
Diseases of the Colon and Rectum|July 21, 2009
A twenty-year experience with adenocarcinoma of the anal canalGeorge J Chang, Ricardo J Gonzalez, John M Skibber, et al.
Expert Opinion on Biological Therapy|August 1, 2022
Biologics in rectal cancerAlexandre A Jácome, Renata D'Alpino Peixoto, Mariana V Gil, et al.
The Oncologist|May 27, 2025
Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancerChristopher Cann, Michael LaPelusa, Sarah Cimino, et al.
Journal of Pain and Symptom Management|February 9, 2018
The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled TrialSarah Prinsloo, Diane Novy, Larry Driver, et al.
Pageof 32